P11362 (FGFR1_HUMAN) Homo sapiens (Human)

Fibroblast growth factor receptor 1 UniProtKBInterProSTRINGInteractive Modelling

822 aa; Sequence (Fasta) ; (Isoform 8; Isoform 17; Isoform 2; Isoform 9; Isoform 3; Isoform 10; Isoform 4; Isoform 11; Isoform 5; Isoform 12; Isoform 6; Isoform 13; Isoform 7; Isoform 14; Isoform 15; Isoform 16; Isoform 18; Isoform 19; Isoform 20; Isoform 21)

Available Structures

72 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of activated receptor tyrosine kinase in complex with substrates
3gqi
 Heteromer
P10686; 		464-770
1×DVT; 1×ACP; 1×MG;
Assess
Crystal structure of a monomeric human FGF9 in complex with the ectodomain of human FGFR1c
5w59
 Heteromer
P31371; 		147-360
3×SO4;
Assess
Crystal Structure of FGF1 complexed with the ectodomain of FGFR1c exhibiting an ordered ligand spec…
3ojv
 Heteromer
P05230; 		147-359
1×SGN;
Assess
CRYSTAL STRUCTURE OF FGF1 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 1…
1evt
 Heteromer
P05230; 		147-359
4×SO4;
Assess
Crystal Structure of a 1:1:1 FGF23-FGFR1c-aKlotho Ternary Complex
5w21
 Heteromer
Q9GZV9; Q9UEF7; 		149-361
7×NAG; 1×ZN;
Assess
Cryo-EM Structure of FGF23-FGFR1c-aKlotho-HS Quaternary Complex
7ysh
 Heteromer
Q9GZV9; Q9UEF7; 		148-360
1×SGN; 1×ZN; 1×CU;
Assess
CRYSTAL STRUCTURE OF A DIMERIC FGF2-FGFR1 COMPLEX
1cvs
 Heteromer
P09038; 		149-359
4×SO4;
Assess
CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX
1fq9
 Heteromer
P09038; 		149-359
1×SGN; 1×SGN;
Assess
Structural Basis of SNT PTB Domain Interactions with Distinct Neurotrophic Receptors
1xr0
 Heteromer
Q8WU20; 		409-430
Assess
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazo…
4nka
homo-2-mer458-765
3×SO4; 3×EDO; 2×2K7;
Assess
Crystal structure of minimal kinase domain of fibroblast growth factor receptor 1 in complex with 5…
3js2
homo-2-mer459-765
2×VM1; 2×PO4;
Assess
Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compou…
4f65
homo-2-mer460-765
4×SO4; 10×EDO; 2×0S9;
Assess
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazo…
4nk9
homo-2-mer460-765
4×EDO; 3×SO4; 2×2K5;
Assess
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1
1fgk
homo-2-mer461-762
Assess
Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compou…
4f64
homo-2-mer461-762
2×0S8; 4×EDO; 1×SO4;
Assess
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074
2fgi
homo-2-mer461-762
2×PD1;
Assess
Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compou…
4f63
homo-2-mer461-762
2×0S7; 4×EDO;
Assess
Crystal Structure of activated receptor tyrosine kinase in complex with substrates
3gql
monomer463-774
1×GQL;
Assess
Native FGFR1 with an inhibitor
5am6
monomer458-765
3×CL; 1×38O;
Assess
FGFR1 mutant with an inhibitor
5am7
monomer458-764
1×38O; 2×CL;
Assess
Crystal Structure of FGFR1 (C488A, C584S) in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETH…
4rwj
monomer458-764
1×66T;
Assess
Crystal structure of Fibroblast Growth Factor Receptor 1 kinase domain
3ky2
monomer458-764
3×SO4;
Assess
Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M) in complex with N-{3-[2-…
4rwk
monomer458-764
1×66T; 1×MG;
Assess
FGFR1 kinase domain with sulfatinib
8jmz
monomer460-765
1×UKI; 6×SO4; 1×GOL;
Assess
Crystal structure of FGFR1 kinase domain with Pemigatinib
7wcl
monomer459-764
1×8ZF; 4×SO4;
Assess
Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M), apo
4rwi
monomer460-764
Assess
Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethox…
3tt0
monomer461-765
1×07J; 3×SO4;
Assess
Structure of the mutant Fibroblast Growth Factor receptor 1
3kxx
monomer461-765
Assess
Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 11.
6p69
monomer462-765
1×SO4; 2×EDO; 1×O21;
Assess
Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to H3B-6527
5vnd
monomer463-765
1×9ES; 2×SO4; 9×EDO;
Assess
FGFR1 kinase domain with a dual-warhead covalent inhibitor CXF-007
8xlo
monomer462-764
1×A1LVQ; 3×SO4;
Assess
DISEASE LINKED MUTATION IN FGFR
5flf
monomer460-762
1×SO4; 1×ACT;
Assess
FGFR1 in complex with dovitinib
5a46
monomer464-766
3×EDO; 1×38O; 2×SO4;
Assess
FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylph…
6nvl
monomer463-765
1×SO4; 1×XL6;
Assess
FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693
5ew8
monomer464-765
2×SO4; 1×5SF;
Assess
FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 38.
7ozb
monomer464-765
1×47I; 2×SO4; 3×EDO;
Assess
FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 34.
7ozd
monomer464-765
1×42I; 5×SO4; 3×EDO;
Assess
Crystal structure of FGFR1 kinase domain in complex with compound 3
6itj
monomer464-765
1×AXU;
Assess
Crystal structure of FGFR1 kinase domain in complex with 7n
4zsa
monomer464-765
1×4UT;
Assess
TAS-120 in reversible binding mode with FGFR1
6mzq
monomer464-765
1×TZ0;
Assess
FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3-methoxybenzyl)-7-azaindole
3c4f
monomer464-765
1×C4F;
Assess
FGFR1 ligand complex
5a4c
monomer464-765
5×SO4; 5×EDO; 1×XOJ;
Assess
FGFR1 kinase complex with inhibitor SN36985
6c19
monomer464-765
1×YY7; 1×SO4;
Assess
TAS-120 covalent complex with FGFR1
6mzw
monomer464-765
1×TZ0; 1×SO4;
Assess
FGFR1 kinase domain complex with SN37333 in reversible binding mode
5ur1
monomer464-765
1×YY9;
Assess
FGFR1 kinase domain complexed with FIIN-1
6c1o
monomer464-765
1×MK9; 1×SO4;
Assess
FGFR1 kinase domain complex with fragment 2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxamide
5uq0
monomer464-765
1×WP1;
Assess
Fibroblast growth factor receptor 1 kinase in complex with JK-P5
4uwb
monomer464-765
3×EDO; 1×JVT; 1×SO4;
Assess
Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 22.
6p68
monomer462-763
1×O1Y; 1×SO4;
Assess
Structure of FGFR1 in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-…
4wun
monomer465-765
1×66T;
Assess
FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 19.
7ozf
monomer465-765
1×466; 1×SO4; 2×EDO; 1×CL;
Assess
Human FGF in complex with a covalent inhibitor
5o49
monomer464-764
1×9K5; 2×SO4;
Assess
Fibroblast growth factor receptor 1 kinase in complex with JK-P3
4uwc
monomer465-765
7×EDO; 1×4Y0; 2×PPI; 4×SO4;
Assess
FGFR1 kinase complex with inhibitor SN37118
6c1b
monomer465-765
1×YY4;
Assess
Human FGF in complex with a covalent inhibitor
5o4a
monomer464-764
2×SO4; 1×GOL; 1×9K8;
Assess
Crystal structure of the catalytic domain of FGFR1 kinase in complex with ARQ 069
3rhx
monomer461-761
1×3RH; 1×SO4; 1×EDO;
Assess
FGFR1 kinase complex with inhibitor SN37116
6c1c
monomer465-765
1×YY6;
Assess
Crystal structure of FGFR1 (C488A, C584C) in complex with 6-(7-((1-aminocyclopropyl) methoxy)-6-met…
4rwl
monomer465-765
Assess
FGFR1 kinase complex with inhibitor SN37115
6c18
monomer465-765
1×YY5; 1×SO4;
Assess
FGFR1 Apo structure
4uwy
monomer462-762
1×PEG; 3×CL;
Assess
FGFR1 in complex with ponatinib (co-crystallisation).
4v01
monomer465-765
4×SO4; 6×EDO; 1×0LI;
Assess
Human FGFR1 kinase in complex with CH5183284
5b7v
monomer464-763
1×LWJ; 1×SO4;
Assess
FGFR-1 in complex with ligand lenvatinib
5zv2
monomer463-762
1×LEV;
Assess
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX W…
1agw
monomer464-762
1×SU2;
Assess
Crystal structure of FGFR1 kinase domain in complex with a novel inhibitor
5z0s
monomer464-762
1×960;
Assess
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX W…
1fgi
monomer464-762
1×SU1;
Assess
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazo…
4nks
monomer465-762
1×2M2;
Assess
Solution structure of the first Ig-like domain of human fibroblast growth factor receptor 1
2cr3
monomer38-123
Assess
cFMS tyrosine kinase in complex with 4-Cyano-1H-imidazole-2-carboxylic acid (2-cyclohex-1-enyl-4-pi…
3krj
monomer577-597
1×ACT; 1×KRJ;
Assess
cFMS Tyrosine kinase in complex with 5-Cyano-furan-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2…
3krl
monomer577-597
1×KRL; 1×SO4;
Assess
cFMS tyrosine kinase in complex with a pyridopyrimidinone inhibitor
3dpk
monomer585-597
3×SO4; 1×8C5;
Assess
Crystal structure of CSF1R kinase domain in complex with DP-6233
7tnh
monomer585-597
1×NA; 4×CL; 1×I9W;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6v6q.1.Ahomo-2-mer0.76463-763
1×MG;81.45
Assess
1ry7.1.Bmonomer0.63152-361
58.23
Assess

50 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26v6q.1.Ahomo-2-mer0.76461-761
1×MG;78.66
Assess
Isoform 21ry7.1.Bmonomer0.62152-361
58.41
Assess
Isoform 36v6q.1.Ahomo-2-mer0.77374-674
1×MG;81.45
Assess
Isoform 33ojv.2.Bmonomer0.6858-270
99.55
Assess
Isoform 46v6q.1.Ahomo-2-mer0.77372-672
1×MG;78.66
Assess
Isoform 41fq9.1.Cmonomer0.7160-270
99.56
Assess
Isoform 56v6q.1.Ahomo-2-mer0.77303-603
1×MG;81.25
Assess
Isoform 57ysh.1.Cmonomer0.701-200
100.00
Assess
Isoform 66v6q.1.Ahomo-2-mer0.77301-601
1×MG;78.66
Assess
Isoform 76v6q.1.Ahomo-2-mer0.76461-761
1×MG;81.45
Assess
Isoform 71ry7.1.Bmonomer0.63150-359
56.92
Assess
Isoform 81e0o.1.Dmonomer0.69152-359
79.05
Assess
Isoform 85a46.1.Amonomer0.67464-646
88.52
Assess
Isoform 81ry7.1.Bmonomer0.64152-361
57.99
Assess
Isoform 84y61.1.Amonomer0.5333-361
21.28
Assess
Isoform 85xwu.1.Cmonomer0.5332-359
22.42
Assess
Isoform 84wrm.1.Amonomer0.5326-360
17.29
Assess
Isoform 84x9i.1.Bmonomer0.5140-359
19.86
Assess
Isoform 91e0o.1.Dmonomer0.68152-359
79.05
Assess
Isoform 95a46.1.Amonomer0.68462-644
88.94
Assess
Isoform 91ry7.1.Bmonomer0.63152-361
57.99
Assess
Isoform 96fwx.1.Amonomer0.6033-249
19.58
Assess
Isoform 95xwu.1.Amonomer0.5532-360
22.34
Assess
Isoform 94y61.1.Amonomer0.5333-361
21.28
Assess
Isoform 101fq9.1.Cmonomer0.7360-270
99.56
Assess
Isoform 101e0o.1.Bmonomer0.7162-270
78.67
Assess
Isoform 102pzr.1.Ahomo-2-mer0.69375-559
72.02
Assess
Isoform 113ojm.1.Bmonomer0.7362-272
69.86
Assess
Isoform 111e0o.1.Bmonomer0.7162-270
78.67
Assess
Isoform 114j96.1.Amonomer0.70367-557
72.02
Assess
Isoform 123ojm.1.Bmonomer0.712-202
69.35
Assess
Isoform 121e0o.1.Bmonomer0.691-199
79.10
Assess
Isoform 123kxx.1.Amonomer0.69301-487
85.71
Assess
Isoform 133ojm.1.Bmonomer0.713-201
69.54
Assess
Isoform 132pzr.1.Amonomer0.71303-486
70.62
Assess
Isoform 131e0o.1.Bmonomer0.691-199
79.10
Assess
Isoform 146v6q.1.Ahomo-2-mer0.77372-672
1×MG;81.45
Assess
Isoform 143ojv.2.Bmonomer0.7058-268
99.55
Assess
Isoform 152ckn.1.Amonomer0.7135-119
94.12
Assess
Isoform 167ysh.1.Cmonomer0.7359-272
77.88
Assess
Isoform 161e0o.1.Bmonomer0.7162-271
60.75
Assess
Isoform 172y8n.1.Bmonomer0.5831-57
37.04
Assess
Isoform 187ysh.1.Cmonomer0.7358-270
77.21
Assess
Isoform 181e0o.1.Bmonomer0.7059-269
60.47
Assess
Isoform 196v6q.1.Ahomo-2-mer0.76463-763
1×MG;81.45
Assess
Isoform 191ry7.1.Bmonomer0.62153-364
57.14
Assess
Isoform 206v6q.1.Ahomo-2-mer0.76453-753
1×MG;78.66
Assess
Isoform 201ry7.1.Bmonomer0.64144-353
57.63
Assess
Isoform 216v6q.1.Ahomo-2-mer0.76494-794
1×MG;81.45
Assess
Isoform 211ry7.1.Bmonomer0.61183-395
62.63
Assess